These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
312 related articles for article (PubMed ID: 26716902)
1. Leukemia inhibitory factor promotes EMT through STAT3-dependent miR-21 induction. Yue X; Zhao Y; Zhang C; Li J; Liu Z; Liu J; Hu W Oncotarget; 2016 Jan; 7(4):3777-90. PubMed ID: 26716902 [TBL] [Abstract][Full Text] [Related]
2. miR520c blocks EMT progression of human breast cancer cells by repressing STAT3. Wang N; Wei L; Huang Y; Wu Y; Su M; Pang X; Wang N; Ji F; Zhong C; Chen T; Li B Oncol Rep; 2017 Mar; 37(3):1537-1544. PubMed ID: 28112380 [TBL] [Abstract][Full Text] [Related]
3. miR-598 inhibits metastasis in colorectal cancer by suppressing JAG1/Notch2 pathway stimulating EMT. Chen J; Zhang H; Chen Y; Qiao G; Jiang W; Ni P; Liu X; Ma L Exp Cell Res; 2017 Mar; 352(1):104-112. PubMed ID: 28161537 [TBL] [Abstract][Full Text] [Related]
4. Anxa2 binds to STAT3 and promotes epithelial to mesenchymal transition in breast cancer cells. Wang T; Yuan J; Zhang J; Tian R; Ji W; Zhou Y; Yang Y; Song W; Zhang F; Niu R Oncotarget; 2015 Oct; 6(31):30975-92. PubMed ID: 26307676 [TBL] [Abstract][Full Text] [Related]
5. microRNA-203 suppresses invasion and epithelial-mesenchymal transition induction via targeting NUAK1 in head and neck cancer. Obayashi M; Yoshida M; Tsunematsu T; Ogawa I; Sasahira T; Kuniyasu H; Imoto I; Abiko Y; Xu D; Fukunaga S; Tahara H; Kudo Y; Nagao T; Takata T Oncotarget; 2016 Feb; 7(7):8223-39. PubMed ID: 26882562 [TBL] [Abstract][Full Text] [Related]
6. Activation of AKT signaling promotes epithelial-mesenchymal transition and tumor growth in colorectal cancer cells. Suman S; Kurisetty V; Das TP; Vadodkar A; Ramos G; Lakshmanaswamy R; Damodaran C Mol Carcinog; 2014 Feb; 53 Suppl 1():E151-60. PubMed ID: 24000138 [TBL] [Abstract][Full Text] [Related]
7. Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD. Meng X; Wu J; Pan C; Wang H; Ying X; Zhou Y; Yu H; Zuo Y; Pan Z; Liu RY; Huang W Gastroenterology; 2013 Aug; 145(2):426-36.e1-6. PubMed ID: 23583431 [TBL] [Abstract][Full Text] [Related]
8. Tumor-suppressive microRNA-34a inhibits breast cancer cell migration and invasion via targeting oncogenic TPD52. Li G; Yao L; Zhang J; Li X; Dang S; Zeng K; Zhou Y; Gao F Tumour Biol; 2016 Jun; 37(6):7481-91. PubMed ID: 26678891 [TBL] [Abstract][Full Text] [Related]
9. Aberrantly expressed Fra-1 by IL-6/STAT3 transactivation promotes colorectal cancer aggressiveness through epithelial-mesenchymal transition. Liu H; Ren G; Wang T; Chen Y; Gong C; Bai Y; Wang B; Qi H; Shen J; Zhu L; Qian C; Lai M; Shao J Carcinogenesis; 2015 Apr; 36(4):459-68. PubMed ID: 25750173 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-9 is associated with epithelial-mesenchymal transition, breast cancer stem cell phenotype, and tumor progression in breast cancer. Gwak JM; Kim HJ; Kim EJ; Chung YR; Yun S; Seo AN; Lee HJ; Park SY Breast Cancer Res Treat; 2014 Aug; 147(1):39-49. PubMed ID: 25086633 [TBL] [Abstract][Full Text] [Related]
11. 53BP1 suppresses epithelial-mesenchymal transition by downregulating ZEB1 through microRNA-200b/429 in breast cancer. Kong X; Ding X; Li X; Gao S; Yang Q Cancer Sci; 2015 Aug; 106(8):982-9. PubMed ID: 26011542 [TBL] [Abstract][Full Text] [Related]
12. The miR-506-Induced Epithelial-Mesenchymal Transition is Involved in Poor Prognosis for Patients with Gastric Cancer. Sakimura S; Sugimachi K; Kurashige J; Ueda M; Hirata H; Nambara S; Komatsu H; Saito T; Takano Y; Uchi R; Sakimura E; Shinden Y; Iguchi T; Eguchi H; Oba Y; Hoka S; Mimori K Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1436-43. PubMed ID: 25707493 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-361-5p inhibits epithelial-to-mesenchymal transition of glioma cells through targeting Twist1. Zhang X; Wei C; Li J; Liu J; Qu J Oncol Rep; 2017 Mar; 37(3):1849-1856. PubMed ID: 28184914 [TBL] [Abstract][Full Text] [Related]
14. miR-195 Inhibits EMT by Targeting FGF2 in Prostate Cancer Cells. Liu C; Guan H; Wang Y; Chen M; Xu B; Zhang L; Lu K; Tao T; Zhang X; Huang Y PLoS One; 2015; 10(12):e0144073. PubMed ID: 26650737 [TBL] [Abstract][Full Text] [Related]
15. Targeting STAT3/miR-21 axis inhibits epithelial-mesenchymal transition via regulating CDK5 in head and neck squamous cell carcinoma. Sun SS; Zhou X; Huang YY; Kong LP; Mei M; Guo WY; Zhao MH; Ren Y; Shen Q; Zhang L Mol Cancer; 2015 Dec; 14():213. PubMed ID: 26690371 [TBL] [Abstract][Full Text] [Related]
16. IL-32θ inhibits stemness and epithelial-mesenchymal transition of cancer stem cells via the STAT3 pathway in colon cancer. Bak Y; Kwon T; Bak IS; Hong J; Yu DY; Yoon DY Oncotarget; 2016 Feb; 7(6):7307-17. PubMed ID: 26824417 [TBL] [Abstract][Full Text] [Related]
17. miR-181b-3p promotes epithelial-mesenchymal transition in breast cancer cells through Snail stabilization by directly targeting YWHAG. Yoo JO; Kwak SY; An HJ; Bae IH; Park MJ; Han YH Biochim Biophys Acta; 2016 Jul; 1863(7 Pt A):1601-11. PubMed ID: 27102539 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-1254 inhibits the migration of colon adenocarcinoma cells by targeting PSMD10. Chu YM; Peng HX; Xu Y; Yang DM; Zhou FL; Li J; Kuai R; Lin Y J Dig Dis; 2017 Mar; 18(3):169-178. PubMed ID: 28296190 [TBL] [Abstract][Full Text] [Related]